These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8395547)

  • 1. Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro.
    Nelson AJ; Hosier S; Brady W; Linsley PS; Farr AG
    J Immunol; 1993 Sep; 151(5):2453-61. PubMed ID: 8395547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
    Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
    J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B70 antigen is a second ligand for CTLA-4 and CD28.
    Azuma M; Ito D; Yagita H; Okumura K; Phillips JH; Lanier LL; Somoza C
    Nature; 1993 Nov; 366(6450):76-9. PubMed ID: 7694153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E; Scarpellino L; Lane P; Acha-Orbea H
    Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two signals are required for negative selection of CD4+CD8+ thymocytes.
    Page DM; Kane LP; Allison JP; Hedrick SM
    J Immunol; 1993 Aug; 151(4):1868-80. PubMed ID: 7688388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
    Lane P; Haller C; McConnell F
    Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor.
    Freeman GJ; Cardoso AA; Boussiotis VA; Anumanthan A; Groves RW; Kupper TS; Clark EA; Nadler LM
    J Immunol; 1998 Sep; 161(6):2708-15. PubMed ID: 9743327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.
    Gajewski TF; Fallarino F; Uyttenhove C; Boon T
    J Immunol; 1996 Apr; 156(8):2909-17. PubMed ID: 8609411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule.
    Chen C; Gault A; Shen L; Nabavi N
    J Immunol; 1994 May; 152(10):4929-36. PubMed ID: 7513726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells.
    Larsen CP; Ritchie SC; Hendrix R; Linsley PS; Hathcock KS; Hodes RJ; Lowry RP; Pearson TC
    J Immunol; 1994 Jun; 152(11):5208-19. PubMed ID: 7514631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of V beta 5+ thymocytes.
    Degermann S; Surh CD; Glimcher LH; Sprent J; Lo D
    J Immunol; 1994 Apr; 152(7):3254-63. PubMed ID: 7511640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a soluble form of CTLA4 on macrophage and its biological activity.
    Hua GY; Wang P; Takagi K; Shimozato O; Yagita H; Okigaki T; Matasumura M
    Cell Res; 1999 Sep; 9(3):189-99. PubMed ID: 10520601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of CD80 and CD86 with CD28 and CTLA4.
    Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
    J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cells and embryoid bodies express lymphocyte costimulatory molecules.
    Ling V; Munroe RC; Murphy EA; Gray GS
    Exp Cell Res; 1998 May; 241(1):55-65. PubMed ID: 9633513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue.
    Vyth-Dreese FA; Dellemijn TA; Majoor D; de Jong D
    Eur J Immunol; 1995 Nov; 25(11):3023-9. PubMed ID: 7489738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
    Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
    J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.